IL176239A0 - Use of gaboxadol for treating insomnia - Google Patents

Use of gaboxadol for treating insomnia

Info

Publication number
IL176239A0
IL176239A0 IL176239A IL17623906A IL176239A0 IL 176239 A0 IL176239 A0 IL 176239A0 IL 176239 A IL176239 A IL 176239A IL 17623906 A IL17623906 A IL 17623906A IL 176239 A0 IL176239 A0 IL 176239A0
Authority
IL
Israel
Prior art keywords
gaboxadol
treating insomnia
insomnia
treating
Prior art date
Application number
IL176239A
Other languages
English (en)
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34684447&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL176239(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of IL176239A0 publication Critical patent/IL176239A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
IL176239A 2003-12-18 2006-06-11 Use of gaboxadol for treating insomnia IL176239A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200301877 2003-12-18
PCT/DK2004/000861 WO2005058313A1 (en) 2003-12-18 2004-12-14 Use of gaboxadol for treating insomnia

Publications (1)

Publication Number Publication Date
IL176239A0 true IL176239A0 (en) 2006-10-05

Family

ID=34684447

Family Applications (1)

Application Number Title Priority Date Filing Date
IL176239A IL176239A0 (en) 2003-12-18 2006-06-11 Use of gaboxadol for treating insomnia

Country Status (17)

Country Link
EP (1) EP1720547A1 (ru)
JP (1) JP2007515415A (ru)
KR (1) KR20060103335A (ru)
CN (1) CN1893942A (ru)
AR (1) AR047154A1 (ru)
AU (1) AU2004298313A1 (ru)
BR (1) BRPI0415893A (ru)
CA (1) CA2550610A1 (ru)
EA (1) EA200600989A1 (ru)
IL (1) IL176239A0 (ru)
IS (1) IS8390A (ru)
MX (1) MXPA06006685A (ru)
NO (1) NO20063320L (ru)
SG (1) SG133601A1 (ru)
TW (1) TW200528098A (ru)
WO (1) WO2005058313A1 (ru)
ZA (1) ZA200602762B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0402118D0 (en) 2004-01-30 2004-03-03 Merck Sharp & Dohme Polymorphic forms of a GABAA agonist
EP1906953A4 (en) * 2005-04-29 2009-05-20 Lundbeck & Co As H FORMS OF ACID SALTS AND BASIC SALTS OF GABOXADOL
WO2019055369A1 (en) * 2017-09-12 2019-03-21 Ovid Therapeutics Inc. USE OF GABOXADOL IN THE TREATMENT OF NARCOLEPSIA
EP3833351A4 (en) 2018-09-20 2021-10-13 Ovid Therapeutics Inc. USE OF GABOXADOL TO TREAT TOURETTE SYNDROME, TICKS, AND STUTTERS
AU2019405489A1 (en) 2018-12-17 2021-06-10 Ovid Therapeutics Inc. Use of gaboxadol for the treatment of non-24 hour sleep-wake disorder
WO2021127308A1 (en) 2019-12-18 2021-06-24 Ovid Therapeutics Inc. GABOXADOL FOR THERAPEUTIC TREATMENT OF 1p36 DELETION SYNDROME

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19525598C2 (de) * 1995-07-13 1997-09-25 Max Planck Gesellschaft Schlafmittel
JP2004530695A (ja) * 2001-05-21 2004-10-07 ハー・ルンドベック・アクチエゼルスカベット ガボキサドールの顆粒状調合物

Also Published As

Publication number Publication date
AR047154A1 (es) 2006-01-11
TW200528098A (en) 2005-09-01
BRPI0415893A (pt) 2007-01-09
ZA200602762B (en) 2007-06-27
MXPA06006685A (es) 2006-08-23
CA2550610A1 (en) 2005-06-30
SG133601A1 (en) 2007-07-30
CN1893942A (zh) 2007-01-10
WO2005058313A1 (en) 2005-06-30
AU2004298313A1 (en) 2005-06-30
KR20060103335A (ko) 2006-09-28
JP2007515415A (ja) 2007-06-14
EP1720547A1 (en) 2006-11-15
IS8390A (is) 2006-03-30
NO20063320L (no) 2006-07-18
EA200600989A1 (ru) 2006-10-27

Similar Documents

Publication Publication Date Title
EP1667680A4 (en) COMBINED METHODS OF TREATING CANCER
IL175351A0 (en) Methods of treating asthma
EP1838714A4 (en) METHODS OF TREATING PAIN
IL178996A0 (en) Thienopyridinone compounds and methods of treatment
EP1613308A4 (en) CANCER TREATMENT METHODS
EP1636359A4 (en) METHODS OF TREATING PAIN
GB0325192D0 (en) Method of use
IL182436A0 (en) Thienopyridinone compounds and methods of treatment
EP1696877A4 (en) PROCESS FOR PAIN TREATMENT
GB0324761D0 (en) Use of compounds in therapy
EP1613266A4 (en) METHOD FOR TREATING PAIN AND COMPOSITIONS FOR USE THEREOF
EP1677794A4 (en) METHODS OF TREATING DISORDERS
IL176239A0 (en) Use of gaboxadol for treating insomnia
EP1653982A4 (en) TREATING BAD ODOR
GB0306309D0 (en) Method of treatment
GB0302572D0 (en) Method of treatment
GB0426196D0 (en) Methods of treatment
GB0217493D0 (en) Novel methods of treatment
ZA200606071B (en) Methods of treating asthma
GB0208897D0 (en) New method of treatment
GB0329416D0 (en) Treatment of cancer
GB0221712D0 (en) Methods of treatment
GB0327975D0 (en) Methods of treatment
IL172528A0 (en) Surface treatment of sars-infected lungs
GB2398069B (en) Treatment of ferrous waste